Skip to main content

Table 2 Clinical outcome of relapsing-remitting-EAE mice treated with hAECs

From: Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis

 

1 × 106 hAECs

5 × 106 hAECs

PBS

Disease incidence

4/7

3/7

7/7

Day disease onset

17.25 ± 5.3

15.7 ± 2.0

16.7 ± 1.6

Death severe disease

1/7

1/7

3/7

Maximum score

1.9 ± 0.6*

1.3 ± 0.7*

3.8 ± 0.5

Cumulative score

24.9 ± 10.2*

20.8 ± 12.0*

57.3 ± 9.79

  1. *P < 0.05 compared to PBS
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094